Treatment of acute migraine.
Miller
Franklin G
FG
D000208:Acute Disease; D001549:Benzamides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018849:Controlled Clinical Trials as Topic; D004992:Ethics, Medical; D006381:Helsinki Declaration; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D015990:Placebo Effect; D011985:Receptors, Serotonin / Q000187:drug effects*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D000096642:Receptor, Serotonin, 5-HT1F
D001549:Benzamides; D007211:Indoles; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D000096642:Receptor, Serotonin, 5-HT1F; C108218:4-fluoro-N-(3-(1-methyl-4-piperidinyl)-1H-indol-5-yl)benzamide